No Data
TD Cowen Maintains Mersana Therapeutics(MRSN.US) With Buy Rating
Mersana Therapeutics (MRSN) Receives a Buy From TD Cowen
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Express News | Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
William Blair Initiates Coverage On Mersana Therapeutics With Outperform Rating